MyMSTeam

Yes! One of the most promising areas of MS research is focused on remyelination therapies. Scientists worldwide are collaborating on developing treatments that could repair damaged myelin. Many leading researchers believe these breakthrough treatments could be available within 5-10 years.

The goal is to activate dormant Show Full Answer

Yes! One of the most promising areas of MS research is focused on remyelination therapies. Scientists worldwide are collaborating on developing treatments that could repair damaged myelin. Many leading researchers believe these breakthrough treatments could be available within 5-10 years.

The goal is to activate dormant oligodendrocytes (which make up 5-8% of brain and spinal cord cells) to rebuild myelin in damaged areas. This could potentially help prevent further progression and maybe even restore some function. Current research is exploring several promising compounds for remyelination:

• S1P receptor modulators (some already approved as DMTs)
• Clemastine fumarate (an antihistamine)
• Sex hormones like testosterone

Additionally, researchers are investigating neuroprotective therapies to slow brain atrophy, which is particularly important for progressive forms of MS. While there have been some setbacks in trials, scientists remain optimistic about developing effective treatments.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

MS Expert Predicts Myelin Repair Therapy Will Emerge Within Next 10 Years

How Myelin Damage Causes MS Symptoms and Ways To Slow Demyelination